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ABSTRACT 
The overall aim of the present thesis was to study the muscular response to repeated bouts of 
30-s sprint exercise. This type of exercise gives rise to a profound metabolic perturbation that 
might counteract an exercise-induced stimulation of muscle protein synthesis. Special focus 
was paid upon nutritional supply and how it can direct the muscular response towards 
activation of amino acid sensors, cell signalling pathway and muscle protein synthesis. Some 
questions were analysed by gender. 
 It was hypothesised that: Amino acids decrease and ammonia increases following sprint 
exercise and more so in males than females. 
Activation of mTOR signalling increases more in females than males in skeletal muscle 
following sprint exercise. Oral ingestion of essential amino acids and carbohydrates increases 
the amino acid sensor Vps34 activity, the amino acid transporter and sensor SNAT2,  
Akt/mTOR signalling and consequently enhances the rate of muscle protein synthesis in 
skeletal muscle following sprint exercise.  
It is concluded that: Plasma leucine decreased and plasma and muscle ammonia increased 
following sprint exercise and more so in in males than females. Such changes might 
counteract a possible sprint exercise-induced stimulation of muscle protein synthesis. There 
was some activation of mTOR signalling in skeletal muscle following sprint exercise and 
more so in females than males. The larger increase in serum insulin and lower decrease in 
plasma leucine in females might have contributed to the enhanced signalling response in 
females. Oral ingestion of essential amino acids and carbohydrates, as compared to placebo, 
resulted in a markedly higher activation of Akt/mTOR signalling in skeletal muscle following 
sprint exercise. In contrast to the hypothesis, an oral ingestion of essential amino acids and 
carbohydrates did not result in an increased activation of hVps34 in skeletal muscle. 
However, this does not exclude the permissive role of hVps34 in mediating the amino acid-
induced activation of Akt/mTOR signalling and skeletal muscle protein synthesis. The 
interaction between the condition (nutrients or placebo) and correlation between increase in 
Vps34 activity and increase plasma glucose may reflect the dual role of Vps34, i.e. sensing a 
nutrient-rich condition and activate mTOR or sensing a nutrient-poor condition and activate 
autophagy in order to counteract low levels of amino acids. Oral ingestion of essential amino 
acids and carbohydrates resulted in a higher SNAT2 expression, a higher activation of 
Akt/mTOR signalling and higher rate of muscle protein synthesis following sprint exercise. 
Thus, nutrients have a potential to stimulate muscle protein synthesis and related pathways 
after sprint exercise, in spite of the profound metabolic perturbation.  
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 INTRODUCTION 1
 “Classical” forms of exercise 1.1
Physical exercise is often broadly classified as either ”resistance” or ”endurance” exercise. 
Resistance exercise is characterised by low-volume/high force muscle actions. For one 
maximal contraction there is no limitation regarding ATP supply and no need for ATP 
regeneration. Instead the limiting factors are mainly related to muscle cross-sectional area and 
contractile properties of the muscle fibres. When forceful muscle contractions are repeated 
the ATP has to be regenerated mainly from creatine phosphate (CP) breakdown and 
anaerobic glycolysis. Endurance exercise is characterised by high-volume, low- to moderate-
intensity work. This type of exercise is associated with ATP regeneration mainly through 
aerobic pathways. The muscular adaptations to repeated bouts of resistance or endurance 
exercise is well characterised (1, 2). Resistance exercise usually results in hypertrophy (1), 
while endurance exercise results in an increased mitochondrial and capillary density (2-4). 
 
 
 Sprint exercise 1.2
In contrast to resistance and endurance exercise, few studies have been carried out to 
investigate the effects of sprint exercise, even though there is an accelerating interest to 
explore the effects of sprint exercise due to unexpectedly found health benefits (5). Sprint 
exercise is similar to resistance exercise with regard to the intense muscular work performed 
during short-duration bouts (6). Yet one sprint bout is typically built up of a more extensive 
number of repetitions against lower absolute resistance than during traditional resistance 
training. Consequently, the limiting factors for power output or speed during sprint exercise 
are muscle mass, contractile properties and anaerobic energy supplies. A popular form of 
sprint exercise among various types of athletes and also among individuals who are training 
to reach health benefits, is sprint or high - intensity interval training. This type of exercise is 
defined as short bursts of vigorous exercise interspersed by periods of low-intensity exercise 
or rest (6). 
There are a numerous of different ways to design such sprint interval training sessions. 
The length and intensity of the active bout of sprint and of the “resting” phase can vary as 
well as the number of “sets”. In the present thesis, focus has been on 30-s all-out sprints 
separated by 20 min of rest, i.e. no exercise was performed during these 20 min. The 
reasoning behind the relatively long resting period was to guaranty a close-to-full recovery of 
the power output and the anaerobic ATP regeneration capacity. If the rest period is 
considerably shorter (i.e. a few minutes), subsequent exercise bouts will show lower power 
outputs and a considerable switch from anaerobic to aerobic ATP generation (7).  
During a 30-s bout of an all-out sprint, ATP has to be regenerated mainly from CP and 
anaerobic glycolysis and to a lesser extent from aerobic pathways. It has been shown that 30-
s of sprint exercise leads to a profound metabolic perturbation and can reduce muscle ATP by 
50%, CP by 80%, and glycogen by 35% in type II muscle fibres (8, 9). In type I fibres the 
reduction of ATP and CP is smaller (8, 9). ATP is broken down to ADP, AMP and finally to 
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IMP and an equimolar amount of ammonia. However, a small portion of the ATP pool is 
further broken down to inosine and hypoxanthine (10). The large accumulation of ammonia 
in plasma and muscle may interfere with amino acid availability and may also interact with 
muscle protein synthesis (11).  
To perform well in sprint exercises there is a need for a large muscle mass and fast 
contracting muscles are beneficial. Thus, a productive sprint-training program should thus 
induce an increase in muscle cross-sectional area (12, 13). Interestingly however, longitudinal 
studies show that such an increase in cross-sectional area is not always the case (12).  In fact, 
there are some observations indicating that sprint exercise may counteract muscle protein 
accretion, such as a lack of activation of signalling pathways related to the translation 
machinery (14). Indeed, Coffey et al. reported that resistance exercise induced Akt/mTOR 
signalling was inhibited when preceded by sprint exercise, indicating that sprint exercise 
could perhaps interfere with muscle hypertrophic responses if employed over time (15). 
 
 
 Muscle protein synthesis and muscle hypertrophy 1.3
Muscle hypertrophy is known to arise if muscle protein synthesis exceeds degradation of 
muscle proteins over an extended period of time (16). Important factors for protein synthesis 
in addition to mechanical stress are amino acid availability and hormones such as insulin, 
growth hormone, testosterone, IGF-1 (17, 18). Most of these stimuli activate the mTOR-
pathway, which is characterized by a cascade of phosphorylation steps leading to the 
increased expression of factors involved in protein translation, transcription, cell proliferation 
and ribosome biosynthesis ultimately stimulating skeletal muscle growth (17, 18). 
While high mechanical stress and muscular forces activates the mTOR-pathway, high 
metabolic stress, i.e. when the AMP/ATP ratio increases during high rate of ATP 
consumption, is associated with AMPK activation. Rodent models have shown that increased 
AMPK activity may inhibit the mTOR pathway and thereby muscle protein synthesis (19). 
Past research support the notion that AMPK is heavily activated by sprint exercise. For 
example, Chen et al 2000 (20) showed a 2-3 fold increase in muscle AMPK activity induced 
by a single 30-s sprint bout. Furthermore, sprint exercise has been shown to induce skeletal 
muscle adaptations typically associated with endurance-type training, i.e. increased 
mitochondrial density and improved oxidative capacity (21). Against this background 
following research questions were formulated: Is the availability of essential amino acids 
affected by sprint exercise and is such change related to the accumulation of ammonia? Is the 
Akt/mTOR pathway activated after sprint exercise? 
 
 
 Gender 1.4
Several gender-related differences in response to single and repeated bouts of sprint exercise 
have been demonstrated both at the muscular and systemic level (22). Following a period of 
sprint training, the fibre cross-sectional area is increased in females but not in males (23). 
Other factors that distinguish males and females in response to sprint exercise are the higher 
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accumulation of lactate, ammonia and catecholamine in plasma, in males (8, 10, 24). 
However, serum insulin increases more in females than males after sprint exercise (25). 
Against this background it is important to study both genders in the experiments and to 
evaluate gender difference during sprint exercise. Therefore, the first research questions in the 
present thesis were analysed by gender. 
 
 
 Nutrient ingestion 1.5
Nutrient supplementation may have a profound effect on post-exercise muscle proteins 
synthesis and on the adaptive response to cumulative training (26-30). It has been shown that 
ingestion of essential amino acids following resistance exercise leads to an even larger 
increase in the rate of muscle protein synthesis compared with the independent effect of 
nutrients or muscle contraction (26). In the last years the branched chained amino acids and 
especially leucine has been studied due of it’s potential to activate muscle protein synthesis 
(31, 32). Interestingly, this seems to be mediated by the activation of the mTOR- pathway 
and subsequent activation of downstream targets (33).  
The effect of nutrient provision on the rate of muscle protein synthesis following 30-s 
bouts of sprint exercise has not been explored yet, even though an increased myofibrillar 
protein synthesis was demonstrated, when repeated 6-s bouts of sprint exercise were 
combined with nutrient provision (15). The metabolic perturbation, however, is much 
stronger after repeated 30-s bouts than after repeated 6-s bouts (15, 34), arguing for a 
requirement of a deeper understanding of the consequences of longer 30-s bouts. Thus, the 
research questions if oral ingestion of nutrients will activate the Akt/mTOR pathway and the 
rate of muscle protein synthesis following 30-s sprint exercise were formulated in the present 
thesis.  
 
 
 Amino acid sensing 1.6
The underlying mechanisms responsible for the stimulatory effect of essential amino acids on 
mTOR signalling and muscle protein synthesis are not fully understood, but several have 
been suggested (35, 36).  
Vps34. From in vitro studies it has been suggests that amino acids stimulate mTOR 
through a class 3 PI3K, the human vacuolar protein sorting 34 (hVps34) (37, 38) and that 
Vps34 might act as an internal amino acid sensor to mTOR (37, 38). Both fuel depletion 
(glucose and amino acid) and AMPK activation inhibit hVps34 (33). It has been shown that 
the activity of Vps34 can be increased by adding glucose or amino acids to cells cultures (37, 
38). Also the protein concentration of hVps34 and phosphorylation of p70S6k was increased 
in human myotubes with leucine supplements (39). These studies show that nutrients affect 
Vps34 and mTOR signalling. Although Vps34 has been studies in rat skeletal muscle (40, 41) 
no studies in response to sprint exercise have been executed on Vps34 activity in human 
skeletal muscle tissue. 
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SNAT2. The amino acid transporter SNAT2 is known to transport amino acids across the cell 
membrane and also to act as sensors for changes in extracellular amino acid concentrations 
and initiator of downstream signalling pathways (42, 43). In rat myotubes, SNAT2 has been 
shown to be a potential regulator of amino acid-dependent signalling (44). Furthermore, 
acidosis as well as the lipid metabolite ceramide was shown to inhibit SNAT2 activity (44, 
45), which may lead to decreased Akt/mTOR signalling and protein synthesis, and to 
increased proteolysis through an insulin-mediated mechanism (43, 44). In contrast, insulin 
has been shown to stimulate SNAT2 in rat myotubes (46). 
An increased expression of this transporter has been demonstrated after resistance 
exercise in human skeletal muscle (47). Upregulation of SNAT2 expression in human 
skeletal muscle has also been observed during amino acid supplementation at rest (48) and 
after resistance exercise (49-51). In contrast, recent work suggests that sprint exercise down 
regulates SNAT2 at the mRNA level (52). However, the influence of nutrient provision on 
amino acid transporters in relation to repeated bouts of sprint exercise, a form of exercise that 
is characterized by a profound metabolic perturbation (8), is not known. Therefore, the 
research questions if oral nutrient ingestion will activate the two amino acid sensors Vps34 
and SNAT2 following sprint exercise was formulated in the present thesis. 
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 AIM OF THE THESIS 2
The overall aim of the present thesis was to study the muscular response to repeated bouts of 
30-s sprint exercise. This type of exercise gives rise to a profound metabolic perturbation that 
might counteract an exercise-induced stimulation of muscle protein synthesis. Special focus 
was paid upon nutritional supply and how it can direct the muscular response towards 
activation of amino acid sensors, cell signalling pathways and muscle protein synthesis. Some 
of the questions were analysed by gender.  
 
It was hypothesised that: 
 Amino acids decrease and ammonia increases in humans following sprint exercise 
and more so in males than in females.  
 
 Activation of mTOR signalling increases more in females than in males in human 
skeletal muscle following sprint exercise. 
 
 Oral ingestion of essential amino acids and carbohydrates increases the amino acid 
sensor Vps34 activity, as well as mTOR signalling in human skeletal muscle 
following sprint exercise.  
 
 Oral ingestion of essential amino acids and carbohydrates increases the expression of 
the amino acid transporter and sensor SNAT2 and Akt/mTOR signalling in and 
consequently enhances the rate of muscle protein synthesis human skeletal muscle 
following sprint exercise. 
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  MATERIAL AND METHODS 3
 Subjects 3.1
All subjects (n=51) in the studies were recruited from nearby universities and sports/health 
clubs. The inclusion criteria were: good health, participation in leisure-time sports, but not at 
an elite level and age 20–35 years. The exclusion criteria were chronic disease, acute 
infection, severe asthma, or use of products containing nicotine. Health was evaluated by a 
general health questionnaire and a 12-lead electrocardiogram registration. A questionnaire 
was used to screen potential subjects for the physical activity level during leisure time (53) 
with the intention to create two groups with a similar range and average level of physical 
activity in study I and II. Fat-free body mass (FFM) was estimated from skinfold 
measurements in triceps, biceps, subscapula and suprailiacal regions (54). In study III and IV 
the maximal oxygen uptake (VO2 max) was determined using a standardised incremental 
cycle test to exhaustion on a cycle ergometer (Siemens-Elema, Solna, Sweden). Oxygen 
uptake was measured continuously utilizing a gas analyser Vmax Encore System (VIASYS 
Healthcare Inc., Yorba Linda, CA). In study I the females were on day 10-28 of their 
menstrual cycle (non-bleeding phase), in order to avoid low oestrogen levels. Six females 
used oral contraceptives. This non-bleeding phase avoids the part of the cycle with the lowest 
oestrogen levels. In Study II females with varying phases of their menstrual cycle were 
selected (day 1 to day 28). Four females used oral contraceptive. The physical characteristics 
of the subjects are presented in Table 1. All subjects were fully informed about the 
procedures and potential risks of the experiment before giving their written and verbal 
consent prior to participation. All studies in the thesis were approved by the Ethics 
Committee of Karolinska Institutet or by the Regional Ethical Review Board in Stockholm, 
Sweden. 
Table 1. The physical characteristics of the subjects in the various studies 
  Gender Number Age  Height  
Body 
mass  
Fat free 
mass  
Body fat 
Activity 
index* 
      years cm kg kg %   
Study I  Female 8 26±7 165±5 64±8 47±7 26±8 17±3 
   Male 6 29±6 177±6 75±10 61±9 18±5 15±1 
    
       Study II Female 8 25±2 170±10 66±12 51±7 22±8 16±1 
   Male 9 26±4 18±6 84±7 73±7 13±5 16±3 
    
       Study III Female 1 23 167 55 46 16       19 
   Male 8 28±5 183±9 80±5 68±5 15±4 15±3 
    
       Study IV Female 3 26±4 171±8 70±4 52±4 26±2 18±2 
   Male 9 27±5 182±8 78±10 67±9 15±5 17±2 
Mean     26±2 175±8 72±10 58±10 19±5 17±1 
   * Activity index: range 5 - 20 
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 Sprint exercise protocol 3.2
The experimental design of the different studies is presented in Fig. 1. In all studies the 
subjects performed the sprint exercise on a mechanically braked cycle ergometer (Cardionics, 
Bredäng, Sweden). After a brief warm up (1 min, with a braking load of 1 kg) the subjects 
were instructed to pedal as fast as possible without any resistance. When maximal pedalling 
speed was reached, an individual’s braking load set at 0.075 kp · kg-1 body weight was 
applied to the flywheel, while the subjects continue to pedal “all out” during 30 seconds. The 
subjects performed in total three 30-s sprint exercise bouts with 20 min rest between the 
sprints (55). The subjects were in a supine position during the rest periods. Peak power (i.e. 
the highest 5-s power) and mean power (the average power during the 30-s sprint exercise) 
were expressed in absolute values (W), relative to body mass (W x kg body mass
-1
) and 
relative to fat-free body mass (W x kg fat- free body mass
-1
). 
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Fig. 1. Experimental protocol for each of the studies in the present thesis, including sprint exercise protocol and 
point of time for muscle and blood sampling 
 
 
 
 
 
 
 10 
 Biopsy sampling 3.3
The protocol for obtaining biopsy samples in the different studies is presented in Fig. 1. In all 
studies skeletal muscle biopsy samples were obtained from the lateral portion of the vastus 
lateralis muscle, ~20 cm above the patella under local anaesthesia without adrenaline by the 
percutaneous biopsy technique (56). All muscle samples (50-100 mg) were quickly dissected 
free of any visible fat and connective tissue and frozen by in liquid nitrogen. In study II 
muscle samples were frozen in isopentane for determination of fibre type composition.  
Muscle samples were stored at -80 ºC for later analyses.  
 
 Nutritional drink   3.4
Studies III and VI were randomised, single-blinded, placebo-controlled, crossover studies     
(Fig.1). The subjects repeated the sprint exercise protocol with or without nutrient ingestion 
with a month interval between the experiments. At both occasions the subjects arrived in to 
the laboratory after an overnight fast from 9 pm the evening before. The subjects were 
instructed to ingest either an essential amino acid or maltodextrin drink, called “EEA+Carb” 
drink in study III or “nutrient drink” in study IV or a placebo drink. The intervention drink 
contained eight essential amino acids, 300 mg x kg body weight
-1
 (Ajinomoto, Kanagawa, 
Japan) and maltodextrin, 1g x kg body weight
-1
 (Faring AB Sports nutrition, Fast Carbs 
Natural, Järfälla, Sweden). Both nutrient and the placebo drinks were “Wild Berrie” 
flavoured and contained salts and artificial sweetener, all to conceal the taste of the amino 
acids (Funlight, Wild Berries, Procordia Food AB, Eslöv, Sweden, diluted 1:4 in water), see 
also Table 2. Each subjects ingested a total volume of 12.5 mL · kg-1 body weight of the drink 
delivered at four occasions (5 min before sprint 1 and 15 min after each sprint), see Fig. 1. 
The reason for adding maltodextrin to the amino acid containing drink was to prevent a 
possible use of amino acids in gluconeogenesis and oxidative processes that might limit the 
amino acid availability for muscle protein synthesis. 
 
Table 2. Amino acid composition of the 
nutritional supplement drink  
Essential amino acids    Weight %  
Histidine 13.7 
Isoleucine 9.4 
Leucine 17.3 
Lysine 18.0 
Methionine 2.9 
Phenylalanine 14.3 
Threonine 13.7 
Valine 10.7 
Total  100 
300 mg x kg body weight
-
1 of the 
essential amino acids and 1g x kg body 
weight
-1
 of maltodextrin were given to 
the subjects. 
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 Blood analysis 3.5
3.5.1 Sample preparation 
Blood samples in the studies were divided into two equal portions.  One portion was 
transferred into sodium- heparinised tubes, and immediately centrifuged at 2000 x g (4°C) for 
10 min. One-millilitre aliquots of this plasma portion was frozen in liquid nitrogen and stored 
at -80°C. The other portion of blood was transferred to a serum tube stored at room 
temperature for 20 min and then treated the same way as the heparinised blood. In study IV 
also small aliquots ( ̴ 200 µL) were taken 100 - 200 min after the last sprint for fractional 
synthetic rate analysis. These small aliquots were treated the same way as the heparinised 
blood. 
 
3.5.2 Glucose, Lactate, Insulin, Ammonia, Growth hormones, FFA 
Glucose concentration was determined, using a Beckman Coulter Oxygen Electrode (LX-20 
Brea, CA, USA). The plasma was pipetted into a reaction cup containing glucose oxidase 
solution. The amount of consumed oxygen is proportional to the concentration of glucose. 
Concentration of plasma lactate was established by applying a Radiometer ABL 800 Flex 
blood gas analyser (Berman & Beving Lab, Triolab, Göteborg, Sweden). An electro-
chemiluminescence immunoassay was used to analyse serum insulin Modular (E170, Roche, 
Pharma, Stockholm, Sweden). Plasma ammonia was analysed using an enzymatic method 
according to van Anken and Shiphorts (57) with the following modifications. We used an 
optical 96-well reaction plate (MicroAmp) and an absorbance microplate reader (Molecular 
device Spectra max plus 384, Sunnyvale, CA, USA) to measure the decrease in absorbance 
Unlike van Anken and Schiphorts, we allowed the reaction to go to completion at a so-called 
end point. Serum growth hormone (GH) was determined using the Immulite 2000 Growth 
Hormone (hGH) chemiluminescent enzyme immunoassay (Diagnostic Products Corporation, 
Germany). Serum concentration of free fatty acids (FFA) was analysed by an enzymatic 
colorimetric assay (Wako Chemicals GmbH, Neuss, Germany) according to manufacturer’s 
instructions. 
 
3.5.3 Amino acids 
Amino acid concentrations were determined by HPLC, using precolumn derivatisation with 
orthophthaldialdehyde/3-mercaptopropionic acid (Alliance, Waters 2690, fluorescence 
detector Waters 474: Waters, Stockholm, Sweden) as described by Vesali et al (58).  
 
 
 Muscle analysis 3.6
3.6.1 Amino acids 
Specimens of muscle tissue for the analysis of amino acids were homogenised using a 
minibead beater (Biospec Products, Bartlesville, Oklahoma, USA) and deproteinised in 4% 
sulfosalicylic acid (SSA) with 0.2mM norvaline as an internal standard in a volume to weight 
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ratio of 20 (mL/mg wet muscle). Amino acids were analysed by an HPLC as described under 
3.5.3. Briefly, amino acids were analysed using precolumn derivatisation with 
orthophthaldialdehyde/3-mercaptopropionic acid on an HPLC system (Alliance, Waters 
2690, fluorescence detector Waters 474: Waters, Stockholm, Sweden). 
 
3.6.2 Immunoblotting 
Muscle samples (~20 mg) were homogenised on ice using glass homogenisers in ice-cold 
homogenisation buffer (20 μL x mg-1 wet weight). The protein concentration of the 
homogenate was determined spectrophotometrically. The samples were diluted with 
homogenisation buffer and Laemmli buffer to a ﬁnal protein concentration of 2 μg x μL-1. 
The diluted protein was denatured (95ºC for 5 min) and stored at −20 °C until further 
analysis.  
Samples containing total protein were loaded and separated by SDS-PAGE on precast 
Criterion TGX gradient gels (BioRad). Gels were subsequently equilibrated in transfer buffer 
(30 min at 4º) and then transferred to a polyvinylidine fluoride membrane. In study IV, the 
transfer of proteins was confirmed through staining of the membranes with MemcodeTM 
Reversible Protein Stain Kit. After blocking for 1h at room temperature in Tris-buffered 
saline containing 5 % nonfat dry milk, the membranes were incubated overnight with primary 
phospho- or total protein specific antibodies diluted in TBS supplemented with 0.1 % Tween-
20 and 2.5 % non-fat dry milk. Next, the membranes were washed serially and incubated for 
1h at room temperature with HRP-conjugated secondary antibodies. Then, the membranes 
were washed serially again and finally the target proteins were visualised by application of 
Super SignalTM West Femto Chemiluminescent Substrate (Thermo Scientific) to the 
membrane. The results were detected using a Molecular Imager ChemiDocTM XRS system. 
In study II and IV, following visualisation, the membranes were stripped of the phosphor 
specific antibodies, using Restore Western Blot Stripping Buffer after which the membranes 
were washed and re-probed with primary antibodies for each respective total protein as 
described above. In study III, the membranes were re-probed with monoclonal anti-α-tubulin 
as a loading control. In study IV, the memcodeTMstaining using memcodeTM was used as 
loading control for SNAT2. 
 
3.6.3 Lipid kinase assay (Study III) 
To produce protein extracts, muscle samples (~30 mg) were powdered under liquid nitrogen 
using a mortar and pestle. Powdered frozen extracts were lysed using analysis buffer 
containing 50 mmol L
-1
 Tris-base pH 7.5, 1 mmol L
-1
 EGTA, 1 mmol
-1
  EDTA, 1 mmol L
-1
 
sodium orthovanadate, 10 mmol L
-1
 b-glycerophosphate, 50 mmol L
-1
  sodium fluoride, 5 
mmol L
-1
  sodium pyrophosphate, 0.27 mol L
-1
  saccharose, 0.1% (v/v)b-mercaptoethanol 
and 0.3% (w/v) 3[(3-Cholamidopropyl) dimethylammonio]-propanesulfonic acid, and 
onetablet (per 10 mL) of Complete protease inhibitor (Roche, Diagnostics, Indianapolis, IN) 
to a final protein extract concentration of 2–5 mg muscle powder mL-1. The protein extract 
was agitated (Vibrax orbital shaker, Sigma-Aldrich, Belfast, Ireland) at 1000 rpm, for 10 min 
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at 4°C and centrifuged at 4°C for 15 min at 16, 000 x g, to remove insoluble material. The 
protein concentration was determined using the DC protein assay (Bio-Rad) utilizing a 
spectrophotometer (Eppendorf BioPhotometer, Hamburg, Germany). Details of the hVps34 
activity assay procedures have been previously published (41) with slight modifications for 
this study. Samples were immunoprecipitated overnight at 4°C with 2 µg of sheep anti-
hVps34 antibody (hVps34 antibodies, for activity measurements and Western blot analysis, 
were obtained from Dr. James Murray’s laboratory at Trinity Biomedical Science Institute, 
Trinity Collage Dublin, Ireland) using a protein extract volume corresponding to 0.7–1.5 mg 
of total protein extract. Vps34 protein complexes were then immobilised on protein-G 
sepharose. Immunocomplexes were washed in Lysis buffer and in 60 µL TNE (10 mmol L
-1
 
Tris-base, pH 7.5, 150 mmol L
-1
 NaCl, 1 mmol L
-1
  EDTA, 0.1 mmol L
-1
  Na3VO4), 
resuspended in TNE+ (TNE, 0.5 mmol L
-1
  EGTA, pH 8.0, 1: 1000 2-mercaptoethanol), and 
incubated with 20 µg hVps34 antigen peptide. Substrates for the assay were prepared by 
adding 10 µL of 100 mmol L
-1
 MnCl2 and 10 µL of 2 mg mL
-1
  phosphoinositol (PtdIns) 
(bovine liver, Avanti Polar Lipids, Alabaster, AL) to each sample. PtdIns was sonicated for 5 
min prior to addition to the assay to generate micelles. Reactions were performed at 30°C 
with shaking throughout the assay and initiated with the addition of ATP mix (1 mmol L
-1
 
unlabelled ATP, [γ-
32
P] ATP, H2O). After 10 min, reactions were terminated by the addition 
of 20 µL of 8 mol L
-1
 HCl and phase separated with 160 µL 1:1 chloroform and methanol and 
centrifuged for 1 min at 16,000 x g. The lower organic phase was spotted on an aluminium-
backed silica TLC gel 60 F254 plate (Merck, Damstadt, Germany) and analysed in a TLC 
chamber solvent system (60-mL chloroform, 47-mL methanol, 11.2-mL water, and 2-mL 
ammonium hydroxide). After the plates had developed sufficiently, they were air dried, 
wrapped in protective film, and exposed to a phosphorimager screen for 24 h before imaging 
with a phosphorimager (FLA-7000, Fujifilm, Tokyo, Japan). Incorporation of [γ-
32
P] ATP 
was quantified using Multi-Gauge software (Fujifilm). 
 
3.6.4 mRNA expression (Study II) 
Total RNA was isolated by homogenising 10-20 mg frozen tissue with a homogenising 
dispenser (Polytron, Kinematica) and a standard TRIzol® protocol (InvitrogenTM Life 
Technologies, Carlsbad, CA, USA). The concentration and purity of the RNA was 
determined using nanodrop (Spectrometer ND-1000: Nanodrop®; Wender Aveen). One 
microgram of total RNA was reverse transcribed using transcription kits from Applied 
Biosystems, Foster City, CA, USA (High-capacity cDNA reverse Superscript) and random 
hexamer primers (Roche Diagnostics GmbH, Mannheim, Germany) in a total volume of 20 
μL reaction. Real-time PCR was used to measure mRNA expression on an ABI-PRISMA 
7700 Sequence Detector (Applied Biosystems Inc., Foster City, CA, USA). Primers and 
probes were supplied as a TaqMan® Reagents kit (Applied Biosystems). RPS18 
(Hs01375212_g1) was used as an endogenous control to correct for potential variation in 
RNA loading errors. All reactions were performed in 96-well MicroAmp Optical plates 
(Applied Biosystems). Amplification reagents (25 μL) contained the sample 5 μl cDNA 
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diluted 1:100 and TaqMan Universal PCR Mastermix. For each individual, all samples were 
simultaneously analysed in duplicate in one assay run. Measurements of the relative 
expression were performed for each individual; a CT value was obtained by subtracting 
RPS18 mRNA CT values from respective target CT values. The expression of each target 
was then evaluated by 2
−ΔΔCT
 and fold changes were calculated for each gene (59). 
 
 
 Fraction synthetic rate analysis (study IV) 3.7
Approximately 40 mg of wet muscle was freeze dried and dissected free of visual blood, fat 
and connective tissue. Approxemately10 mg of the freeze-dried muscle tissue was 
homogenised in 500 µL 4 % sulfosalicylic acid (SSA) and left on ice for 1h before 
centrifugation (10 min, 16,600 x g, 4°C). The supernatant was saved for amino acid analysis. 
The pellet was washed in 4 % SSA and dissolved in 1 mL 0.3 M NaOH and left for 1 h in a 
37°C. Proteins were precipitated with 40 % SSA, incubated for 10 min on ice followed by 
centrifugation (10 min, 16600 x g). Protein pellets were washed with 4 % SSA and then 
hydrolysed for 24h in 6 M HCL at 110°C. The hydrolysed samples were dissolved in 0.5 M 
trisodium citrate, pelleted (5 min, 10,600 x g), and decarboxylated into phenyl-ethylamine 
using a suspension containing 2 mg tyrosine-decarboxylase and 0.25 mg pyridoxal 
phosphate. Samples were incubated over night at 50°C, before adding 6 M NaOH centrifuged 
(10 min, 16,600 x g) the following day. To extract the phenyl-ethylamine, the supernatant 
was mixed with diethyl ether. The mix was shaken and placed in an ethanol bath with dry ice. 
When the bottom layer had frozen, the liquid ether phase was transferred to a new tube 
containing 0.1 M HCL and the phenyl-ethylamine was back-extracted to an aqueous phase 
from the ether phase. The tubes were shaken and placed in ethanol bath and the bottom layer 
containing phenyl-ethylamine was frozen and the ether phase was discarded. Sample were 
transferred to GC-MS vials, dried and then derivatised by N-metyl-N-(tert- butyldimetysilyl) 
trifluouroacetamide and ethyl acetate (ratio 1:1) incubated at 60°C for 1h. The ratio of 
labelled to unlabelled phenylalanine was measured by monitoring ion 180 (m+2) and 183 
(m+5) of the derivatised phenyl-ethylamine. The analysis of protein-bound tracer abundances 
was carried out by analysing the ratio of labelled and unlabelled phenylethylamine to a 
standard curve containing 0-0.189 atomic percent excess (APE) of L-[2H5] phenylalanine 
and treated the same way as the samples. 
Muscle precursor enrichment: To determined muscle tissue fluid enrichment of free 
phenylalanine, the supernatant from the homogenised muscle was purified on resin columns 
(AG 50 W-X8 resin, Bio-Rad Laboratories, Hercules, CA, USA). After being washed, eluted 
using 4 M NH4OH and dried in a rotary evaporator (Speedvac) (24 h), the purified amino 
acids were derivatised by N-metyl-N-(tert- butyldimetysilyl) trifluouroacetamide and ethyl 
acetate (ratio 1:1) incubated at 60°C for 1h. Muscle tissue fluid enrichment of phenylalanine 
as well as enrichment of the standard curve was measured using GC-MS by selective ion 
monitoring for 336 and 341 m/z. 
Plasma precursor enrichment: Plasma samples were deproteinised using 40 % 
sulfosalicylic acid (SSA) and left on ice for 10 min before centrifugation (15 min, 20, 800 x 
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g, 4°C). The supernatant was purified, derivatised and analysed as described above for the 
muscle free fraction. 
Fractional synthesis rate calculation: Mixed muscle protein fractional synthetic rate was 
calculated both with plasma and muscle tissue fluid enrichment as precursors pool, as 
follows: 
 FSRplasma = (ΔE / (Eplasma x t)) x 100 
 FSRmuscle = (ΔE / (Emuscle x t)) x 100 
ΔE is the difference in protein bound L-[2H5] phenylalanine enrichment between biopsies 
taken 200 min and 80 min after sprint 3. Eplasma is the AUC for L-[2H5] phenylalanine 
enrichment in plasma between the two biopsies. Emuscle is the muscle tissue free L-[2H5] 
phenylalanine enrichment in the biopsies. The time period for tracer incorporation in hours is 
denoted by t. To express FSR in percent per hour (% h) values were multiplied by 100. FSR 
was also calculated using the ratio of the muscle tissue free phenylalanine enrichment in the 
biopsies and the corresponding phenylalanine enrichment in plasma as a correction factor to 
weighting the average of the Eplasma, titled FSRadjusted (60). 
 
 
 Statistical analysis 3.8
Generally, a two-way ANOVA was used to study the effect of gender and time or between 
conditions (nutrient or placebo) and time. In the case of significant interaction, a one-way 
ANOVA of repeated measures design or Student’s t-test for paired observations or 
independent groups were used to evaluate specific changes by time or gender. Values in the 
text are means ± standard error (SE) or standard deviation (SD) unless otherwise stated. The 
P values were accepted as statistically significant at P ≤ 0.05. Correlations were calculated by 
Pearson's correlation coefficient. No corrections for multiple comparisons were performed 
due to the limited use of multiple post hoc comparisons.  
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 SUMMARY OF STUDY I-IV 4
For experimental protocols and subject characteristics for study I-IV, see Fig. 1 and Table 1. 
 
 
 Study I 4.1
Previous studies have shown a pronounced difference between males and females in the 
accumulation of ammonia in plasma after sprint exercise. There are no studies on gender 
differences on exercise-induced changes in amino acid levels, although there are studies 
exploring the effects of exercise, regardless of gender, on amino acid levels (61-66) 
It was hypothesised that amino acid levels would decrease while ammonia levels would 
increase in humans following repeated 30-s of bouts of sprint exercise and more so in males 
than females.  
The major findings were that sprint exercise induced a decrease in plasma amino acids, 
especially leucine (Fig. 2A). This decrease was 2-fold higher in males than in females. The 
accumulation of ammonia both in plasma (Fig. 2B) and in muscle (data in paper I is show in 
table 3) was smaller in females compared to males.  A correlation was shown between the 
decrease in plasma leucine and the accumulation of muscle ammonia (Fig. 3). 
It was concluded that plasma leucine decreased while plasma ammonia increased following 
sprint exercise and more so in in males than in females. Such changes might counteract a 
possible sprint exercise-induced stimulation of muscle protein synthesis. 
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Fig. 2. (A) Plasma leucine and (B) Plasma ammonia concentration at rest and during the course of three bouts of 
sprint exercise with 20 min rest in between in eight females (closed symbols) and six males (open symbols). 
Values are the mean ± SE. 
 
 
 
 
 
 
 
 
Fig. 3. Correlation between the exercise-induced decrease in arterial plasma leucine (rest -9 min after sprint 3) 
and the muscle ammonia content 18 min after sprint 2 in six females (closed symbols) and six males (open 
symbols). 
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 Study II 4.2
As shown in study I, males showed a more pronounced decline in plasma leucine following 
sprint exercise. An earlier sprint training study showed a greater increase in muscle typ II 
fibre cross-sectional area in females than males (23). However, the effect on Akt/mTOR 
signalling pathway, an important link in the regulation of muscle protein synthesis, is not so 
well studied in relation to gender.  
It was hypothesised that the activation of the mTOR signalling pathway is more 
pronounced in females than in males in skeletal muscle, following repeated 30-s bouts of 
sprint exercise. 
The major findings were that plasma lactate (Fig. 4A) increased and plasma leucine 
decreased (data shown in paper II) during the sprints and more so in males. Serum insulin 
increased by sprint exercise and more so in females than in males (Fig. 4B). Phosphorylation 
of Akt in skeletal muscle increased by 50 % (Fig. 5A) and mTOR by 120 % (Fig. 5B) 
independent of gender. The elevation in p70S6k phosphorylation was greater in females (Fig. 
5C) and averaged 230 % as compared to 60 % in males. The increase in the phosphorylation 
of p70S6k was directly related to the increase in serum insulin (Fig. 5D).  
It was concluded that some activation of mTOR signalling occurred in skeletal muscle 
following sprint exercise, and that this activation was greater in females than in males. The 
larger increase in serum insulin and lower decrease in plasma leucine might have contributed 
to the enhanced signalling response in females.  
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Fig. 4. (A) Plasma lactate and (B) serum insulin concentration at rest and during the course of three bouts of 
sprint exercise with 20-min rest in between in eight females (closed symbols) and nine males (open symbols). 
Values are the mean ± SE. 
 
 
 
 
 
Fig. 5. (A) Phosphorylation of Akt
Ser473
, (B) mTOR
Ser2448
, (C) p70S6k
Thr389
 pre-exercise and 140 min post-
exercise in eight women (hatched bars) and nine men (white bars). (D) Correlation between exercise-induced 
increase in (d) phosphorylation of Akt
Ser473
 (140 min post-exercise – rest) on the one hand and exercise induced 
increase in insulin concentration (peak-rest) on the other in seven women (closed symbols) and nine men (open 
symbols). Values are arbitrary units (a.u.) and mean ± SE. 
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 Study III 4.3
In study II it was shown that the increase in Akt/mTOR-signalling in skeletal muscle 
following sprint exercise was relatively low, especially in males. This could have been the 
result of decreases in amino acids and especially concentration of leucine, which was also 
higher in the males. Therefore, the question was raised if the activation of Akt/mTOR 
signalling could be increased by ingestion of amino acids. Further, the mechanisms how 
amino acids are sensed in the cell are not fully known. One suggested nutrient sensor is the 
class III phosphatidylinositol 3-kinase, vacuolar protein sorting 34 (Vps34), not previously 
studied in human skeletal muscle.  
It was hypothesised that oral ingestion of essential amino acids and carbohydrates 
increase the activity of the amino acid sensor Vps34 activity and Akt/mTOR signalling in 
human skeletal muscle following repeated 30-s bouts of sprint exercise.  
The major findings were that oral ingestion of nutrients increased the accumulation of 
plasma leucine and serum insulin markedly between 18 to 140 min after sprint 3 compared to 
placebo (Fig 6A, 6B). Plasma glucose accumulation increased somewhat more in in the 
nutrition condition (Fig. 6C). After the last sprint, glucose decreased by 25 % independent of 
condition. The exercise-induced increase in plasma lactate was somewhat smaller in nutrient 
condition (data shown in paper III). A marked increase was shown in phosphorylation of both 
mTOR and p70S6k in the nutrient condition (Fig. 7B; 7A) 140 min after the last sprint, 
compared to placebo. The activity of Vps34 was not significantly changed from the resting 
state by nutrients 140 min after the last sprint (Fig.7C). However, hVps34 activity tended to 
increase in the placebo condition. A negative correlation was seen between the increase in 
hVps34 activity and plasma glucose levels expressed as AUC in placebo condition, whereas a 
positive correlation was seen in the nutrient condition (Fig. 7D). 
It was concluded that oral ingestion of essential amino acids and carbohydrates, as 
compared to placebo, resulted in a markedly higher activation of Akt/mTOR signalling in 
human skeletal muscle following sprint exercise. On contrast to the hypothesis, an oral 
ingestion of essential amino acids and carbohydrates did not result in an increased activation 
of hVps34 in human skeletal muscle. However, this does not exclude the permissive role of 
hVps34 in mediating the amino acid-induced activation of Akt/mTOR signalling and skeletal 
muscle protein synthesis. The interaction between the condition (nutrient or placebo) and 
correlation between increase in Vps34 activity and increase plasma glucose may reflect the 
dual role of Vps34, i.e. sensing a nutrient-rich condition and activating mTOR or sensing a 
nutrient-poor condition and activating autophagy in order to counteract low levels of amino 
acids. 
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Fig. 6. (A) plasma leucine (B) serum insulin and (C) plasma glucose concentration at rest and during the course 
of three bouts of sprint exercise with 20-min rest in nutrient (hatched bars) or placebo (white bars) condition in 
seven subjects. Values are the mean ± SE; c = condition; t = time. Significant difference between the conditions 
is denoted by *P < 0.05, **P < 0.01, ***P < 0.001. 
 
 
Fig. 7. (A) Phosphorylation of mTOR
Ser2448 
and (B) p70S6k
Thr389 
relative to alfa-tubulin at rest pre-exercise and 
140 min post exercise during nutrient (hatched bars) or placebo (white bars) condition in nine subjects. Values 
are arbitrary units (a.u.) and mean±SE; c = condition; t = time. (C) Activity of hVps34 and (D) correlation 
between the sprint exercise-induced increase in Vps34 activity and plasma glucose concentration (before sprint 
1–9 min after sprint 2. Note the opposite slopes when comparing the two conditions. Values are arbitrary units 
(a.u.) and mean ± SE; c = condition; t = time. 
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 Study IV 4.4
The increase in Akt/mTOR signalling with oral amino acid supplement combined with sprint 
exercise in study III indicates that the muscle protein synthesis is increased. Further, the 
mechanisms how amino acids are sensed in the cell are not fully known. One suggested 
nutrient sensor is the amino acid transporter and sensor SNAT2.  
It was hypothesised that oral ingestion of essential amino acids and carbohydrates 
increases the expression of the amino acid transporter and sensor SNAT2 and Akt/mTOR 
signalling in human skeletal muscle following repeated 30-s bouts of sprint exercise and 
consequently enhances the rate of muscle protein synthesis.  
The major findings were that in the nutrient condition both plasma leucine and serum 
insulin accumulation peaked at 80 min after the last sprint and were 2.6-fold and 4-fold 
higher compared to placebo (Fig. 8A, 8B). Four subjects vomited after exercise during the 
nutrient condition and showed only a minor increase in plasma leucine. They were not 
included in the group comparisons, but in the correlation analyses (Fig. 8A). Post exercise 
increase in serum FFA was lower in nutrient condition (for data see paper IV). The 
phosphorylation of Akt, mTOR and p70S6k were all higher in the nutrient compared to the 
placebo condition 80 min and 200 min following sprint exercise (Fig. 9A, 9B, 9C). The rate 
of muscle protein synthesis was measured as the fractional synthesis rate (FSR). The post-
sprint FSRplasma (enrichment based on plasma phenylalanine) in the nutrient compared to 
the placebo condition was 44 % higher. The FSRmuscle (enrichment based on intramuscular 
phenylalanine) or FSRadjusted (enrichment based on intramuscular phenylalanine) did not 
reach a significant difference between the nutrient and the placebo condition (Fig 10A, 10B, 
10C) but showed a similar trend to increase in the nutrient condition.  A positive correlation 
was found between post-exercise FSRplasma and the increase in plasma leucine in nutrient 
conditions (r = 0.70; P =0.02). Positive correlations were also found in the nutrient condition 
between both post-exercise FSRplasma and FSRmuscle on the one hand and serum insulin 
levels as estimated by area under the curve (r = 0.84; P < 0.001 and r = 0.68; P = 0.02). These 
correlations could be considered as a kind of validation of the FSR measurements and 
justifies the conclusion that FSR was increased in the post sprint exercise condition by 
nutrients. SNAT2 expression was higher at both mRNA (1.4-fold) and protein level (40 % 
higher) after the nutrient than after the placebo 200 min post-exercise (Fig 11A, 11B). 
 It was concluded that nutrient ingestion increased the expression of the amino acid 
transporter SNAT2 and the Akt/mTOR signalling after acute sprint exercise, and that this was 
accompanied by enhanced rate of muscle protein synthesis following sprint exercise. Thus, 
nutrients have a potential to stimulate protein synthesis and related pathways after sprint 
exercise, in spite of the profound metabolic perturbation. 
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Fig. 8. (A) plasma leucine, (B) serum insulin concentration at rest, during the course of three bouts of sprint 
exercise with 20 min rest in between and during recovery after the last sprint in nutrient (closed symbols) and 
placebo condition (open symbols) in eight subjects. Values are mean ± SE. Grey lines represent the four subjects 
that vomited and thereby retained a lower nutrient dose. *denotes a significant difference at the level of least 
p<0.05. 
 
 
 
 
 
Fig. 9. (A) Phosphorylated Akt
Ser47
/totAkt, (B) mTOR Ser
2448
/tot mTOR, (C) p70S6k
Thr389
/tot p70S6k 80 min 
and 200 min post exercise in nutrient (black bars) and placebo condition (white bars). Values are arbitrary units 
(a.u.) and mean ± SE in eight subjects. CON (hatched bars) are resting values from a matched control group of 
four subjects. The interactions between condition and time are denoted c x t. 
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Fig. 10. (A) FSRplasma, (B) FSRadjusted, (C) FSRmuscle in nutrient (black bars) and placebo (white bars) 
condition. Values are mean ± SE in 8 subjects. FSRadjusted denotes an adjusted calculation of FSRmuscle 
according to Mikkelsen et al (60), see methods.  
 
 
 
 
 
 
 
 
Fig. 11. (A) Gene expression of SNAT2/SLC38A2 and (B) protein expression of SNAT2 at 80 and 200 min after 
the last third sprint in nutrient (black bars) and placebo (white bars) condition in eight subjects. Values are 
arbitrary units (a.u.) mean ± SE. CONS (hatched bars) are resting values from a matched control group of four 
subjects The interactions between condition and time are denoted c x t. # The statistics is based on relative 
changes, because these were closer to a normal distribution curve than the absolute changes. 
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 METHODOLOGICAL CONSIDERATIONS 5
 Nutrient ingestion and plasma amino acids 5.1
There was no increase in plasma essential amino acids (EEA), when comparing basal rest 
with 9 min after the last sprint in the nutrient condition. Between basal rest and 9 min after 
the last sprint, no samples were collected for amino acid analysis in study IV. The reason for 
this was that in study III, with the same study protocol, only minor or no increases were 
found between basal rest and 9 min after the last sprint. In both studies III and IV a marked 
increase occurred first between 18 and 80 min post-exercise. The reason for this delayed 
increase in plasma EEA might be related to the large sympathoadrenergic activation during 
this type of sprint exercise (8) and thereby a vasoconstriction in the gastrointestinal tract and 
a delayed gastric emptying. In four of the subjects the combined effect of sprint exercise and 
oral ingestion of the drink resulted in an involuntary vomiting. The plasma amino acids in 
these subjects were more similar to the corresponding levels in the subjects in the placebo 
condition (Fig. 8A). 
 
 
 Fractional synthetic rate 5.2
A stable isotope tracer technique was applied in the present study to measure FSR. One 
prerequisite is an accurate assessment of a labelled precursor for protein synthesis in order to 
measure the precursor enrichment. There are strong supports for that t-aminoacyl-tRNA is a 
true precursor (67, 68). However, the very low concentration of aminoacyl-tRNA in tissues 
limits the use of this precursor, especially in in vivo experiments in humans (69, 70). 
Therefore, surrogate precursor pools have been used in the majority of studies. Commonly 
studied surrogate pools are the plasma and the skeletal muscle intracellular pool (tissue fluid 
pool) of labelled amino acids for estimation of the precursor enrichment. In the literature an 
agreement between various surrogate precursor pools and aminoacyl-tRNA varies between 
e.g. species, tissues, tracers and experimental set up can be found (71). Therefore, it is 
difficult to find support for the choice of a specific precursor that is validated for each 
experimental set up and study question. A single study on human skeletal muscle addressed 
the various precursor pools in comparison to aminoacyl-tRNA (70) and found that the plasma 
precursor-based measurements of FSR underestimated the “true” FSR (based on labelled 
aminoacyl-tRNA) and that the precursor pool based on the tissue fluid pool (skeletal muscle) 
overestimated the “true” FSR. Thus, based on studies of human skeletal muscle there is no 
consensus on which precursor pool gives the most accurate estimate of the true precursor. 
This is despite reports from other species and experimental models indicating that the tissue 
fluid-based pools represents the most accurate values of the true precursor (72). In contrast, 
additional methodology has been proposed to give even more accurate estimations of by the 
plasma pool precursor (73). However, it has been shown even if the absolute values for FSR 
as calculated by using the plasma precursor pool or the tissue fluid pool significantly differed, 
the changes in FSR in skeletal muscle after metabolic perturbations like feeding or insulin 
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infusion were in the same direction, independently of precursor pool used, in the calculations 
of FSR (74, 75). In the current study the absolute values are of less importance, rather the 
study question was related to changes induced by the nutrient ingestion. 
In the present study both the plasma and the skeletal muscle tissue pool of labelled 
amino acids were used for estimation of the precursor enrichment. The enrichment of 
precursor in the plasma pool showed a close to steady state level during the measurement 
period, even though there were some changes in enrichment at the end of the experiment. 
However due to the frequent sampling of plasma this change is controlled for in the AUC 
calculation of the precursor enrichment. The enrichment of precursor in the muscle tissue 
pool was based on only two biopsy samples and there was a decrease in enrichment under 
placebo conditions. Due to the limited number of samples available for this analysis, the 
average enrichment is rather uncertain. Combined with the fact that only two points of 
measurements were available, comparison to the calculation of FSRmuscle is less accurate 
than the calculation of the FSRplasma. The FSRplasma was 44 % higher under nutrient 
conditions than in the placebo condition, but the FSRadjusted and FSRmuscle values did not 
reach significance, despite the fact that the average values were 23 % and 15 % higher, 
respectively in the nutrient compared to the placebo condition. Moreover, there were high 
correlations between the FSRplasma and the FSRmuscle in each of the conditions and 
correlations between FSR and AUC for plasma insulin were demonstrated for both 
precursors, see Figs. 8C, 8D shown in paper IV. 
Collectively, the mean value comparisons (nutrients vs placebo), the correlations 
between FSRplasma and FSRmuscle and the correlations between both FSRplasma and 
FSRmuscle and plasma insulin strengthen the validity of the measurements of MPS in the 
present study. It is therefore justified to conclude that nutrient supplementation stimulated the 
MPS after sprint exercise.  
Finally, an interesting finding in the present study was that the difference between 
FSRplasma and FSRmuscle was much smaller than previously reported (71). An important 
difference between the current study and those reported by Smith et al (71), is that the FSR in 
the current study was measured in a post-exercise phase with muscle hyperaemia (76), while 
previous reports measured FSR at rest without a preceding exercise session. 
 
 
 Repeated biopsies  5.3
One limitation in study IV was that MPS only was exclusively measured in the post-exercise 
period, i.e. no data on MPS at rest are available. Therefore, it is not possible to draw any 
conclusion about the effect of sprint exercise per see on MPS from the data in the present 
study. One reason for this choice of study protocol, with the current limitations, was to avoid 
very long experimental time periods with increasing interference of fasting and circadian 
rhythms. Another reason was to avoid a potential damaging effect of repeated muscle 
biopsies. Several studies in the literature show such effect of repeated biopsies (77-80) but 
not all (81). To get an estimation of the basal resting levels for the specific proteins analysed 
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by Western blot, these proteins were also analysed in a separate control group of four age- 
and physical activity-matched subjects, from which biopsies were obtained only at rest. 
Also in study II, there was a limitation that only one biopsy was taken during the post-
exercise period. As in study IV a residual effect of a preceding biopsy on protein activation 
was to be avoided. However, it cannot be excluded that an earlier transient increase in 
hVps34 activity following the last bout of exercise, related to the period of with increasing 
plasma EAA level, had occurred. However, the plasma EAA levels were still clearly elevated 
at the time of the post-exercise biopsy obtained 140 min after the last sprint, suggesting 
activation conditions for hVps34. Further studies are necessary to explore the possibility of 
transient hVps34 activation. 
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 GENERAL DISCUSSION 6
 Major aims and findings 6.1
The overall aim of the present thesis was to study the muscular response to sprint exercise 
including recovery and especially how nutritional supply can direct this response towards 
activation of amino acid sensors, cell signalling pathways and muscle protein synthesis.  
Muscle hypertrophy is known to occur when muscle protein synthesis exceeds degradation of 
muscle proteins. Mechanical stress, amino acid availability and hormone exposure are known 
to stimulate the protein synthesis (17, 18).   
To perform sprint exercise and delivering the highest possible power, there is a need for 
a large muscle mass and fast contracting muscles are required. However, longitudinal studies 
show that sprint training not always increases muscle cross-sectional area (12). For example, 
following a period of sprint training, the fibre cross-sectional area increased in females but 
not in males (23).  
There are numerous of different ways to design sprint exercise or sprint interval 
training protocols. The length and intensity of the active bout of sprint and the number of 
“sets” can vary vastly.  Another critical issue is the length of the “resting” phase. The present 
thesis focused on 30-s all-out sprints separated by 20 min of rest periods, i.e. no exercise was 
performed during these 20 min. The reason for the relatively long resting period was to get as 
close to full recovery as possible of the anaerobic ATP storage. Longer resting periods may 
also allow for more favourable prerequisites for muscle hypertrophy. If the resting period is 
too short the exercise will switch from anaerobic to aerobic ATP generation and the power 
output becomes depressed (7), which may favour aerobic adaptations.  
Sprint exercise is characterised by a large anaerobic ATP regeneration during the active 
phase. Repeated 30-s bouts of exercise influence both central cardiovascular and peripheral 
skeletal muscle functions. The focus in the current thesis has been on factors related to 
regulation of muscle mass. One 30-s bout of sprint exercise give rise to a profound metabolic 
perturbation and can markedly reduce muscle ATP, creatine phosphate and glycogen levels, 
especially in type II muscle fibres (9), with a large accumulation of e.g. ammonia and lactate, 
catecholamines, growth hormone and also an increase in insulin. Most of these sprint exercise 
effects are related to gender, with smaller changes occurring in females with the exception of 
insulin and growth hormone levels (8, 25).  
In the first part of this thesis (study I and II) focus was placed on factors related to 
gender-specific changes in muscle mass, such as amino acid availability, insulin exposure and 
muscle Akt/mTOR signalling (Fig.11).  
Major findings included the observation that sprint exercise decreased arterial plasma leucine 
levels more profoundly in males than in females. This reduction was directly related to the 
increase in muscle ammonia, i.e. the larger the increase in muscle ammonia the larger the 
reduction in plasma leucine. In addition, sprint exercise lead to a greater increase of 
Akt/mTOR signalling in skeletal muscle of females in comparison to males. Moreover, serum 
insulin increased more significantly in females during the sprint exercise period in 
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comparison to males, and that an increase in Akt and p-70S6k phosphorylation respectively 
was correlated to the exercise-induced increase in serum insulin (AUC).  
The second part of this thesis (study III and IV) focused on the effects of oral ingestion 
of essential amino acids and carbohydrates on factors related to muscle hypertrophy such as 
Akt/mTOR signalling, amino acid sensing and rate of MPS (Fig.12) 
The major findings in this second part of the thesis were that oral ingestion of essential 
amino acids and carbohydrates, following sprint exercise, resulted in a markedly higher 
activation of Akt/mTOR signalling as compared to placebo, in skeletal muscle. In contrast to 
the initial hypothesis, oral ingestion of essential amino acids and carbohydrates did not result 
in increased activation of the amino acid sensor hVps34 in skeletal muscle. However, this 
does not exclude the permissive role of hVps34 in mediating the amino acid induced 
activation of the mTOR-pathway and skeletal muscle protein synthesis. Furthermore, oral 
ingestion of essential amino acids and carbohydrates, after sprint exercise, resulted in a higher 
expression of the amino acid transporter SNAT2 and a higher rate of muscle protein 
synthesis. Thus, nutrients have the potential to stimulate muscle protein synthesis and related 
pathways, despite of the profound metabolic perturbation, observed after sprint exercise. 
 
 
 Sprint exercise and cell signaling  6.2
In an earlier study on repeated 30-s sprint exercise no activation of the Akt/mTOR pathway 
was found (14). Instead, the authors reported increased AMPK and p38 MAPK signalling, 
suggesting the induction of mitochondrial biogenesis in skeletal muscle (82). However, the 
study by Gibala et al. included only male participants (14), which might have contributed to 
the different results between these two studies. The divergent results could also be explained 
by different lengths of the rest periods, which were 20 min in the current as compared to only 
4 min in the Gibala et al. study. The length of the rest period may be critical for the muscle 
perfusion and consecutive activation of the Akt/mTOR pathway and muscle protein 
synthesis. The muscle blood flow and perfusion is most likely of importance for the 
activation of mTOR signalling and muscle protein synthesis (83). In fact, a marked post-
exercise hyperaemia has been demonstrated following a 30-s bout of sprint exercise (76), 
which allows for an enhanced inflow of important nutrients and stimulators of protein 
synthesis, such as amino acids and glucose (83, 84). 
 
 
 Sprint exercise and gender 6.3
The exercise-induced increase in the phosphorylation of p70S6k has been shown to be a good 
marker for increased muscle protein synthesis (15, 85-87) and hypertrophy (88, 89). 
However, dissociation between changes in Akt/mTOR signalling and muscle protein 
synthesis has been demonstrated in a non-exercise situation (90). Therefore, findings from 
signalling events could not directly be translated into conclusions regarding muscle protein 
synthesis. However, the larger increase in the phosphorylation of p70S6k in females than 
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males, as found in study II, is in line with the previous finding of an increased in the type II 
fibre cross-sectional area in females but not in males, in response to a four-week session of 
sprint training (23). 
There are, to the best of our knowledge, very few studies on cell signalling following 
sprint exercise analysed by gender. As mentioned above, Gibala et al. (14) found no increase 
mTOR signalling following 30-s bouts of sprint in males, but they did not compare with 
females. Fuentes et al (91) compared the response to one 30-s bout of sprint exercise in males 
and females with regard to cell signalling related to an activation of mitochondrial pathways. 
They found that ACC beta phosphorylation, a downstream target for AMPK activation, 
tended to increase more in the males than in the females that is in accordance with a lower 
mTOR signalling in males.  
Possible explanations for the presented gender difference in sprint exercise-induced 
activation of p70S6k signalling might be (Fig.12): 
1) The different ammonia and plasma leucine levels observed in males and females might 
contribute to the reduced mTOR signalling in males. Ammonia has been shown to inhibit 
mTOR (92), and is less activated when leucine availability is reduced (84).  
2) The greater breakdown of ATP level in type II fibres was faster in males than in females, 
during repeated bouts of sprint exercise, and this may have potentiated an activation of 
AMPK, a known mTOR inhibitor (93).  
3) The lower increase in serum insulin levels in males in comparison to females, in response 
to sprint exercise, may reduce the Akt/mTOR activation. Lower plasma insulin levels in 
males may also contribute to a lower muscle protein accretion due to less inhibition of MPB 
(90) and to a lower SNAT2 activation (46).  Thus, there are several potential mechanisms 
behind the gender-related difference in cell signalling response to sprint exercise. 
Support for a sprint exercise-induced inhibition of Akt/mTOR signalling of MPS was 
found by Coffey et al, who demonstrated that resistance-exercise induced activation of 
Akt/mTOR Akt/mTOR signalling was inhibited when preceded by sprint exercise (15). 
The explanations for the, in the current thesis, presented metabolic, hormonal and cell 
signalling differences between males and females are not fully known. Possibly gender-
related differences in muscle fibre composition and body composition may contribute to the 
explored gender-related differences. Females generally have a larger relative type I fibre area 
(94, 95). ATP depletion and IMP accumulation are much lower in type I than in type II fibres. 
In mixed muscle ATP depletion and IMP, ammonia and lactate accumulation is lower after 
30-s bouts of sprint exercise as demonstrated in study I. There are also typically gender 
differences in body composition, where females have a smaller relative muscle mass and a 
larger relative fat mass. Females also have a smaller muscle mass relative to blood or plasma 
volume (10). Therefore, certain obtained concentration of e.g. muscle lactate or ammonia is 
diluted in a, relative to muscle mass, larger blood or plasma volume. Moreover, the relatively 
larger fat mass may constitute a sink or buffer for ammonia (24). Finally, a more favourable 
condition for tissue perfusion after sprint exercise in females than males, i.e. lower plasma 
catecholamines and higher serum insulin, may add to the gender-related differences in muscle 
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fibre composition and body composition to explain some of the presented differences 
between males and females the current thesis. 
 
 
 
 
 
 
 
 
Fig. 12. Schematic presentation of differences between males and females in acute and chronic response to sprint 
exercise. Indicated blood-borne substances, intramuscular anaerobic metabolism and relevant signalling 
pathways are especially based on results from the current thesis and from earlier sprint exercise studies (8, 20, 
23). Pathways, transport and metabolic reactions are presented in bold in the gender with the most profound 
activations or inhibitions. a.a = amino acids 
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 Sprint exercise and nutrients  6.4
One question is if acute sprint exercise-induced changes in MPS can predict changes in 
muscle protein accretion. A prerequisite, however, for an increase in muscle protein 
accretion, is a positive net balance between muscle protein synthesis and breakdown (MPB) 
and ideal this balance would be measured to predict such changes. In the present study, MPB 
was not measured and thereby net protein balance could not be calculated. However, the 
potentiated response in serum insulin, after nutrient ingestion during the sprint exercise 
session and especially after the last sprint, could have led to a reduced MPB. In a human 
clamp experiment it was demonstrated, that insulin reduced MPB up to a systemic level of 30 
mU x L
-1
 (90). Thus, the nutrient- increased MPS in the current thesis together with a 
potential decreased in MPB will increase the protein net balance.  In fact, a reduced net 
protein balance was supported by the divergent changes in intramuscular tyrosine between 
the two conditions in the current study suggesting that, the net protein balance was enhanced 
by nutrients during the post-sprint exercise period. 
Another question is if the nutrient-induced increase in serum insulin, as presented in 
paper IV, could have contributed to the increased MPS or to an increased net protein balance 
in the nutrient condition. The finding of a large increase in Akt and PRAS40 phosphorylation 
indicates that insulin signalling was activated (96) and therefore might have potentiated the 
mTOR signalling and rate of MPS (97). Also the positive correlation between MPS and AUC 
for serum insulin in the nutrient condition supports this idea, even though this relationship 
might simply reflect a direct relationship between MPS and plasma EEA. In fact, literature 
data strongly support that insulin above basal levels do not further stimulate MPS under the 
prerequisite of an optimal amino acid availability in experiments performed at rest (90, 98) or 
after resistance exercise (51, 99-103), even though there are some conflicting results (104-
106). Thus, no conclusion can be drawn from the present study regarding the influence of 
insulin on MPS.  
 
 
 Amino acid sensing 6.5
The underlying mechanisms responsible for the stimulatory effect of essential amino acids on 
mTOR signalling and muscle protein synthesis are not fully known (35, 36). 
Vps34. (Fig.13). In vitro work suggested that amino acids could stimulate mTOR 
signalling through the class 3 PI3K, the human vacuolar protein sorting 34 (hVps34) (38). 
Additionally, it has been proposed that the hVps34 might act as an internal amino acid sensor 
to mTOR after resistance exercise, thus forming the basis of the current experimental 
hypothesis. The hypothesis in this study was based on in vitro experiments, showing that 
Vps34 is activated by amino acids or glucose (37, 38, 41). 
Study III presents, to our knowledge, for the first time data on hVps34 activity in 
human skeletal muscle, the first ones reported in the literature. However, contrary to our 
hypothesis, the hVps34 activity tended to increase following sprint exercise in the placebo 
condition, i.e. a nutrient-poor condition. The interaction reported between increased hVps34  
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Fig. 13. Schematic presentation of differences between nutrient-rich and nutrient-poor (placebo) condition in 
acute response to sprint exercise. Indicated blood-borne substances, intramuscular anaerobic metabolism and 
relevant signalling pathways are especially based on results from the current thesis. Pathways, transport and 
metabolic reactions are presented in bold in the condition with the most profound activations or inhibitions. 
 a.a. = amino acids 
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activity and plasma glucose levels in the nutrient and in placebo condition (Fig. 7D), 
highlight the complexity of hVps34 activation and regulation. It supports the model of the 
dual functions of this enzyme (107). One of these functions is to control growth by activating 
mTOR in nutrient-rich conditions. The other one is to induce autophagy during nutrient-poor 
conditions. These opposing roles of Vps34 are thought to be possible by the formation of 
spatially distinct Vps34 containing complexes mediating either mTOR activation and cell 
growth or autophagy (107, 108).  
SNAT2. (Fig.13). Amino acid transporters are required for the transport of amino acids 
across the cell membrane, but can also act as sensors for changes in extracellular amino acid 
concentrations and initiate downstream signalling (42, 109). Findings reported in paper IV 
show increased gene and protein expression of the amino acid transporter and sensor SNAT2, 
as a result of nutrient ingestion during the early post-exercise period. In addition to the 
increased EEA availability, increased serum insulin and lowered serum FFA may contribute 
to the increased expression of SNAT2 in the nutrient condition (45, 46). In earlier studies of 
human skeletal muscle, oral ingestion of amino acids at rest (48) and after exercise (48-50) 
has been shown to increase expression of SNAT2 at both the mRNA and protein levels. The 
work reported here, for the first time, observe nutrient-induced changes in SNAT2 protein 
content after sprint exercise, possibly induced by the found increase in SNAT2 gene 
expression. 
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 CONCLUSIONS 7
It is concluded that: 
 
 Plasma leucine decreased and plasma ammonia increased, following sprint exercise 
and more so in males than in females. Such changes might counteract a possible 
sprint exercise-induced stimulation of muscle protein synthesis. 
 
 There was some activation of mTOR signalling in human skeletal muscle following 
sprint exercise. This activation was more pronounced in females than in males. The 
larger increase in serum insulin and lower decrease in plasma leucine might have 
contributed to the enhanced signalling response in females. 
 
 Oral ingestion of essential amino acids and carbohydrates, as compared to placebo, 
resulted in a markedly higher activation of Akt/mTOR signalling in human skeletal 
muscle following sprint exercise. In contrast to our initial hypothesis, an oral 
ingestion of essential amino acids and carbohydrates did not result in an increased 
activation of hVps34 in human skeletal muscle, instead it tended to increase in the 
placebo condition.  However, this does not exclude the permissive role of hVps34 in 
mediating the amino acid-induced activation of Akt/mTOR signalling and skeletal 
muscle protein synthesis. The interaction between the condition (nutrients and 
placebo) and the correlation between the increase in Vps34 activity and the increase 
in plasma glucose may reflect the dual role of Vps34, i.e. sensing a nutrient-rich 
condition and activate mTOR or sensing a nutrient-poor condition and activate 
autophagy in order to counteract low levels of amino acids. 
 
 Oral ingestion of essential amino acids and carbohydrates resulted in a higher SNAT2 
expression, a higher activation of Akt/mTOR signalling and a higher rate of muscle 
protein synthesis following sprint exercise in humans. Thus, nutrients have a potential 
to stimulate protein synthesis and related pathways after sprint exercise, in spite of the 
profound metabolic perturbation. 
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 FUTURE PERSPECTIVES 8
The results in the present thesis may have implications for designing performance-related 
training programmes for athletes as well as health-related training programmes in health and 
disease. The results have increased the understanding of muscular response to severe 
metabolic stress in males and females, and how to direct the response by oral ingestion of 
nutrients towards increased muscle protein synthesis. For example, a sprinter needs both a 
large muscle mass and fast contracting muscles to develop high power. If sprint training leads 
to a decreased muscle protein synthesis, this may counteract the gains obtained by strength 
training sessions. Therefore, it is important to optimise the sprint training sessions with regard 
to post-exercise muscle (myofibrillar) protein synthesis. Another future perspective is 
treatment of anabolic resistance in e.g., ageing and various chronic diseases with sprint 
exercise combined with nutrient supply. This kind of exercise activates type II fibres that 
commonly are atrophied in muscle wasting and may stimulate muscle protein synthesis in 
these fibres. Moreover, the sprint exercise combined with nutrient supply may induce an 
increased inflow of substrates and hormones during the pronounced post sprint exercise 
hyperaemia. There is, however, a need to follow up the results in the current thesis by 
performing longitudinal studies on the effect of nutritional supply on changes in muscle mass 
or muscle cross-sectional area following sprint training in various populations. 
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